These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 494182)

  • 1. The antiheparin effect of alpha1-acid glycoprotein probably due to steric hindrance of the heparin-thrombin interaction.
    Andersen P; Godal HC
    Thromb Res; 1979; 15(5-6):857-68. PubMed ID: 494182
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced antiheparin effect of desialyzed alpha 1-acid glycoprotein.
    Andersen P; Andersen S; Brosstad F
    Thromb Res; 1980 Mar; 17(6):865-71. PubMed ID: 7404492
    [No Abstract]   [Full Text] [Related]  

  • 3. The antiheparin effect of alpha 1-acid glycoprotein: influence on heparin tolerance during the acute phase reaction.
    Andersen P; Kierulf P; Godal HC
    Thromb Res; 1981 Jun 1-25; 22(5-6):593-602. PubMed ID: 6171047
    [No Abstract]   [Full Text] [Related]  

  • 4. Inactivation of thrombin by antithrombin III on a heparinized biomaterial.
    Goosen MF; Sefton MV; Hatton MW
    Thromb Res; 1980 Dec 1-15; 20(5-6):543-54. PubMed ID: 7233384
    [No Abstract]   [Full Text] [Related]  

  • 5. The antiheparin effect of a heparinoid, pentosan polysulphate. Investigation of a mechanism.
    Scully MF; Kakkar VV
    Biochem J; 1984 Mar; 218(3):657-65. PubMed ID: 6202294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin BM from human plasma: an antithrombin binding moderately to heparin.
    Wunderwald P; Schrenk WJ; Port H
    Thromb Res; 1982 Feb; 25(3):177-91. PubMed ID: 6175043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific binding between human neutrophils and heparin.
    Leculier C; Benzerara O; Couprie N; Francina A; Lasne Y; Archimbaud E; Fiere D
    Br J Haematol; 1992 May; 81(1):81-5. PubMed ID: 1520630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Heparin and antiheparin in young children. 1. Report: development of a method for determining heparin and antiheparin in the antithrombin-thrombin system].
    Domula M; Weissbach G
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(5):808-23. PubMed ID: 6188669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antiheparin effect of alpha1-acid glycoprotein and platelet material, evaluated by the heparin thrombin clotting time.
    Andersen P; Godal HC
    Haemostasis; 1977; 6(6):339-46. PubMed ID: 611047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin cofactor and antithrombin.
    Abildgaard U
    Thromb Diath Haemorrh; 1975 Feb; 33(1):38-42. PubMed ID: 47193
    [No Abstract]   [Full Text] [Related]  

  • 11. Human antithrombin III-derived heparin-binding peptide, a novel heparin antagonist.
    Onoue S; Nemoto Y; Harada S; Yajima T; Kashimoto K
    Life Sci; 2003 Oct; 73(22):2793-806. PubMed ID: 14511765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of esterase and amidase activities of alpha- and beta-thrombin in the presence of antithrombin III and heparin.
    Borsodi A; Machovich R
    Biochim Biophys Acta; 1979 Feb; 566(2):385-9. PubMed ID: 570423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antithrombin and antiheparin effects of crude and highly purified alpha 1-acid glycoprotein.
    Andersen P; Kierulf P; Elde AT; Godal HC
    Thromb Res; 1980 Aug; 19(3):401-8. PubMed ID: 7434322
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreased binding of heparin to antithrombin following the interaction between antithrombin and thrombin.
    Carlström AS; Liedén K; Björk I
    Thromb Res; 1977 Dec; 11(6):785-97. PubMed ID: 601749
    [No Abstract]   [Full Text] [Related]  

  • 15. Chromatography of heparin on sepharose-lysine: molecular size fractionation and its relevance to thrombin and antithrombin III binding.
    Hatton MW; Berry LR; Kaur H; Koj A; Regoeczi E
    Can J Biochem; 1979 Oct; 57(10):1183-90. PubMed ID: 120212
    [No Abstract]   [Full Text] [Related]  

  • 16. Purification and characterization of hereditary abnormal antithrombin III with impaired thrombin binding.
    Jørgensen M; Petersen LC; Thorsen S
    J Lab Clin Med; 1984 Aug; 104(2):245-56. PubMed ID: 6747440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of collagen on thrombin inactivation by antithrombin-III and heparin.
    Blaskó G; Bédi J; Machovich R; Pálos LA
    Haematologia (Budap); 1977; 11(1-2):163-8. PubMed ID: 615087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invalidation of concerns with long-term use of heparin: thrombin/antithrombin III interactions.
    Goosen MF; Sefton MV
    Trans Am Soc Artif Intern Organs; 1982; 28():451-5. PubMed ID: 7164279
    [No Abstract]   [Full Text] [Related]  

  • 19. Purification and properties of guinea pig antithrombin III.
    Heck L; Rosenberg R; Remold H
    Prep Biochem; 1979; 9(4):359-77. PubMed ID: 504072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the kinetic behavior of human and bovine proteins in the heparin-catalyzed antithrombin III/thrombin reaction.
    Cunningham MT; Nelsestuen GL
    Biochim Biophys Acta; 1987 Jan; 911(1):66-70. PubMed ID: 3790599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.